Issue |
BIO Web Conf.
Volume 72, 2023
2023 International Conference on Food Science and Bio-medicine (ICFSB 2023)
|
|
---|---|---|
Article Number | 02009 | |
Number of page(s) | 5 | |
Section | Cell Biology and Pharmaceutical Engineering Research | |
DOI | https://doi.org/10.1051/bioconf/20237202009 | |
Published online | 08 November 2023 |
MALAT1 affects atherosclerosis by regulating endothelial cell’s microautophagy
School of Information Engineering, Ocean University of China, Qingdao, Shandong 266000, China
* Corresponding author. Email: zhangrunqi@stu.ouc.edu.cn
Autophagy of vessels endothelial cells is the critical pathological process in atherosclerosis (AS). Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a kind of long non-coding RNA (lncRNA) that regulates the autophagy of vessels endothelial cells, including microautophagy. However, the relationship between AS and MALAT1 is not completely understood, and microautophagy has been ignored. In this study, I designed the experiments to research the impact of MALAT1 in endothelial cells, which could regulate the progression of AS. In the present study, I design to establish the AS model mice with low MALAT1 level. The expression level of MALAT1 needs to be detected to verify the mouse model. Then, the intensity of microautophagy of endothelial cells of mouse model and normal mouse are detected by RT-qPCR, immunofluorescence assay, and observation directly with electron microscope. The atherosclerosis progression and plaque stability are detected by comparing the rations of macrophage/vascular smooth muscle cell and collagen/lipid. This paper only provides theoretical experiment design and possible results about how MALAT1 affects AS by regulating microautophagy of vascular endothelial cells (VECs) which needs additional research in the pathology of atherosclerosis. This paper provided the possibility that MALTA1 regulates the microautophagy in VECs and MALTA1 may be the target to cure AS.
© The Authors, published by EDP Sciences, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.